These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11391794)

  • 1. Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7.
    Boulay JL; Mild G; Reuter J; Lagrange M; Terracciano L; Lowy A; Laffer U; Orth B; Metzger U; Stamm B; Martinoli S; Herrmann R; Rochlitz C
    Genes Chromosomes Cancer; 2001 Jul; 31(3):240-7. PubMed ID: 11391794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
    Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
    J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
    Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No SMAD4 hypermethylation in colorectal cancer.
    Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
    Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
    Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
    Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
    Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L
    Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
    Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
    Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse Smad4 gene.
    Hohenstein P; Molenaar L; Elsinga J; Morreau H; van der Klift H; Struijk A; Jagmohan-Changur S; Smits R; van Kranen H; van Ommen GJ; Cornelisse C; Devilee P; Fodde R
    Genes Chromosomes Cancer; 2003 Mar; 36(3):273-82. PubMed ID: 12557227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad4 deficiency in cervical carcinoma cells.
    Baldus SE; Schwarz E; Lohrey C; Zapatka M; Landsberg S; Hahn SA; Schmidt D; Dienes HP; Schmiegel WH; Schwarte-Waldhoff I
    Oncogene; 2005 Jan; 24(5):810-9. PubMed ID: 15531914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMAD4 as a prognostic marker in colorectal cancer.
    Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
    Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.
    Lassus H; Salovaara R; Aaltonen LA; Butzow R
    Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
    Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
    J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mad-related genes in the human.
    Riggins GJ; Thiagalingam S; Rozenblum E; Weinstein CL; Kern SE; Hamilton SR; Willson JK; Markowitz SD; Kinzler KW; Vogelstein B
    Nat Genet; 1996 Jul; 13(3):347-9. PubMed ID: 8673135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta.
    Ijichi H; Otsuka M; Tateishi K; Ikenoue T; Kawakami T; Kanai F; Arakawa Y; Seki N; Shimizu K; Miyazono K; Kawabe T; Omata M
    Oncogene; 2004 Feb; 23(5):1043-51. PubMed ID: 14762439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway.
    Watanabe Y; Kinoshita A; Yamada T; Ohta T; Kishino T; Matsumoto N; Ishikawa M; Niikawa N; Yoshiura K
    J Hum Genet; 2002; 47(9):478-83. PubMed ID: 12202987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity.
    Hummer BT; Bartlett C; Henry E; Weissman BE
    J Cell Physiol; 2003 Mar; 194(3):289-302. PubMed ID: 12548549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
    Halder SK; Beauchamp RD; Datta PK
    Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad2 and Smad4 gene mutations in hepatocellular carcinoma.
    Yakicier MC; Irmak MB; Romano A; Kew M; Ozturk M
    Oncogene; 1999 Aug; 18(34):4879-83. PubMed ID: 10490821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning of Smad2, Smad3, Smad4, and Smad7 from the goldfish pituitary and evidence for their involvement in activin regulation of goldfish FSHbeta promoter activity.
    Lau MT; Ge W
    Gen Comp Endocrinol; 2005 Mar; 141(1):22-38. PubMed ID: 15707600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.